Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Common Side Effects of Quizartinib and Management Strategies(1) Common side effects of quizartinib involve multiple systems, with higher incidences including: leukopenia (which may···【more】
Article source：Captain MedicineRelease date：2026-07-29Recommended：139
What is Quizartinib?(1) Quizartinib (generic name: quizartinib) is a prescription targeted therapy specifically indicated for the treatment of adult patients with acute myeloid leu···【more】
Article source：Captain MedicineRelease date：2026-07-28Recommended：196
Dacomitinib - Early Identification of Interstitial Lung Disease (ILD)Although the incidence of ILD is low, its potentially fatal nature requires a "zero-tolerance" monito···【more】
Article source：Captain MedicineRelease date：2026-07-24Recommended：174
Dacomitinib Dermatologic Adverse Reactions and Management StrategiesRash and exfoliative skin reactions are highly characteristic adverse reactions of dacomitinib, and their incide···【more】
Article source：Captain MedicineRelease date：2026-07-22Recommended：169
Dacomitinib Indications and Basic Drug OverviewDacomitinib is an oral EGFR tyrosine kinase inhibitor whose core indication is positioned as first-line treatment for metastatic non-···【more】
Article source：Captain MedicineRelease date：2026-07-21Recommended：232
Enasidenib Side EffectsEnasidenib may cause a life-threatening side effect called differentiation syndrome. This syndrome can occur as early as 1 day after the first dose and up to···【more】
Article source：Captain MedicineRelease date：2026-07-20Recommended：199
Filgotinib Dosage and AdministrationThe standard recommended dose is 200 mg orally once daily (or 100 mg based on disease status and initial regimen). For rheumatoid arthritis pati···【more】
Article source：Captain MedicineRelease date：2026-07-17Recommended：215
Drug Profile of DaprodustatDaprodustat is an oral small-molecule drug developed by GlaxoSmithKline Trading Services Limited, with the active ingredient daprodustat. The drug was or···【more】
Article source：Captain MedicineRelease date：2026-07-16Recommended：220
Precautions for filgotinibFilgotinib has not been studied in individuals under 18 years of age; safety, efficacy, and pharmacokinetic data are lacking. Therefore, it is strictly pr···【more】
Article source：Captain MedicineRelease date：2026-07-15Recommended：211
Precautions for the Use of FilgotinibMalignancies, Skin Cancer, and Smoking HistoryJAK inhibitors may theoretically affect tumor immune surveillance, thus requiring attention to ma···【more】
Article source：Captain MedicineRelease date：2026-07-14Recommended：188
Composition and Mechanism of Action of FilgotinibFilgotinib is a prescription drug whose core active ingredient is filgotinib, a member of the Janus kinase (JAK) inhibitor family. ···【more】
Article source：Captain MedicineRelease date：2026-07-13Recommended：195
Special Risk Concerns with PirtobrutinibPirtobrutinib may affect cardiac electrophysiological stability, with reports of new‑onset or worsened atrial fibrillation, atrial flutter, ···【more】
Article source：Captain MedicineRelease date：2026-07-10Recommended：219
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
